Collaborative trial with Alliance for Clinical Trials in Oncology will evaluate new approaches to increase germline genetic testing among at-risk family members Research will also assess the clinical ...

So it's important to remember that all human beings have a risk of colorectal cancer. About 1 in 23 men will be diagnosed with colorectal cancer and about 1 in 25 women, but about 5 to 10% of those ...

The trial will assess if direct outreach by healthcare providers increases cascade genetic testing among first-degree relatives.

The diagnosis of Lynch syndrome in patients with colorectal cancer has evolved from reliance on clinical criteria to integrated molecular and genetic approaches. Genetic testing strategies typically ...

For years, a diagnosis of colon cancer meant potential surgery followed by a painful round of chemotherapy to kill the remaining cancer cells. One-size-fits-all treatment was normal. A new blood test ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. March is Colon Cancer Awareness Month, an important time to ...

Labcorp joins a national CRC trial as exclusive genetic testing provider, expanding Invitae-based testing and supporting ...

Fact checked by Jennifer Klump Key Takeaways The American Cancer Society now recommends stool-based tests and a blood test as ...

In the largest genetic study of inflammatory bowel disease (IBD) traits to date, researchers have identified a genetic marker that is associated with more severe ulcerative colitis and Crohn's disease ...